• Explore /
  • Poster
  • / 18F-fluciclovine positron emission tomography (PET) in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate.

18F-fluciclovine positron emission tomography (PET) in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate.

Abstract Video & Slides Poster

Authors

Pedro Barata

Pedro C. Barata

Tulane University School of Medicine, New Orleans, LA

Pedro C. Barata , Charlotte Manogue , Ellen Jaeger , Malcolm Light , Patrick Cotogno , Elisa Marie Ledet , Janeiro Goffin , Jodi Lyn Layton , Brian E. Lewis , A. Oliver Sartor

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session: Advanced Prostate Cancer

Track

Prostate Cancer - Advanced

Sub Track

Imaging

Clinical Trial Registration Number

NCT04158245

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr TPS171)

DOI

10.1200/JCO.2021.39.6_suppl.TPS171

Abstract #

TPS171

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Neal D. Shore

First Author: Neeraj Agarwal

First Author: Susan F. Slovin

First Author: Christophe Massard